Latest / Research To Practice | Oncology Videos
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
Featuring perspectives from Dr Matthew D Galsky, including the following topics:
HER2 alterations in urothelial cancer and current targeting approaches (0:00)
Key findings supporting the use of trastuzumab deruxtecan for patients with HER2-overexpressing cancers as part of the Phase II DESTINY-PanTumor02 study (9:39)
Targeting of HER2 using disitamab vedotin both as a monotherapy and in combination with other treatments (14:31)
Case: A man in his late 70s with a history of non-muscle-invasive bladder cancer who develops HER2-positive lung metastases (28:57)
Case: A man in his late 60s who…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.